Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology
- 5 February 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 59 (5) , 1840-1853
Abstract
The orphan G protein-coupled receptor GPR55 has been proposed as a novel receptor of the endocannabinoid system. However, the validity of this categorization is still under debate mainly because of the lack of potent and selective agonists and antagonists of GPR55. Binding assays are not yet available for GPR55 screening, and discrepancies in GPR55 mediated signaling pathways have been reported. In this context, we have designed and synthesized novel GPR55 ligands based on a chromenopyrazole scaffold. Appraisal of GPR55 activity was accomplished using a label-free cell-impedance-based assay in hGPR55-HEK293 cells. The real-time impedance responses provided an integrative assessment of the cellular consequence to GPR55 stimulation taking into account the different possible signaling pathways. Potent GPR55 partial agonists (14b, 18b, 19b, 20b, and 21–24) have been identified; one of them (14b) being selective versus classical cannabinoid receptors. Upon antagonist treatment, chromenopyrazoles 21–24 inhibited lysophosphatidylinositol (LPI) effect. One of these GPR55 antagonists (21) is fully selective versus classic cannabinoid receptors. Compared to LPI, the predicted physicochemical parameters of the new compounds suggest a clear pharmacokinetic improvement.Keywords
Funding Information
- University of Toronto
- Consejo Superior de Investigaciones Cient?ficas (JAE-Pre-2010-01119)
- Ministerio de Econom?a y Competitividad (SAF2012-40075-C02-02, SAF2015-68580-C2-1-R, SAF2015-68580-C2-2-R)
- European Social Fund Plus (JAE-Pre-2010-01119)
- Comunidad de Madrid (S2010/BMD-2308)
This publication has 51 references indexed in Scilit:
- Evaluation of Impedance-Based Label-Free Technology as a Tool for Pharmacology and Toxicology InvestigationsBiosensors, 2013
- Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by CannabinoidsJournal of Biological Chemistry, 2012
- Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55Chemistry and Physics of Lipids, 2011
- Pharmacological characterization of GPR55, a putative cannabinoid receptorPharmacology & Therapeutics, 2010
- Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid LigandsJournal of Biological Chemistry, 2009
- The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivoProceedings of the National Academy of Sciences, 2009
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M currentProceedings of the National Academy of Sciences, 2008
- GPR55: a new member of the cannabinoid receptor clan?British Journal of Pharmacology, 2007
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effectsBritish Journal of Pharmacology, 2007